A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

by | May 30, 2025 | Clinical Trials | 0 comments

​ Conditions: Healthy

Interventions: Drug: AZD1613; Drug: Placebo

Sponsors: AstraZeneca; Parexel

Not yet recruiting Conditions: Healthy
Interventions: Drug: AZD1613; Drug: Placebo
Sponsors: AstraZeneca; Parexel
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *